言語を選択

CD45RO

CD45RO 詳細

英語名	Leukocyte common antigen	市販薬剤の数	0
治験薬の数	7	ターゲットの別称	PTPRC，T200，CD45，Protein Tyrosine Phosphatase， Receptor Type C，CD45 Antigen，L-CA，Protein Tyrosine Phosphatase， Receptor Type， C Polypeptide，Receptor-Type Tyrosine-Protein Phosphatase C，T200 Leukocyte Common Antigen，Leukocyte Common Antigen，T200 Glycoprotein，EC 3.1.3.48，CD45R，GP180，B220，LCA，LY5，Leukocyte Common Antigens，Protein Tyrosine Phosphatase Receptor Type C，EC:3.1.3.48
研究＆開発段階	Phase 3 Clinical

英語名	Leukocyte common antigen
ターゲットの別称	PTPRC，T200，CD45，Protein Tyrosine Phosphatase， Receptor Type C，CD45 Antigen，L-CA，Protein Tyrosine Phosphatase， Receptor Type， C Polypeptide，Receptor-Type Tyrosine-Protein Phosphatase C，T200 Leukocyte Common Antigen，Leukocyte Common Antigen，T200 Glycoprotein，EC 3.1.3.48，CD45R，GP180，B220，LCA，LY5，Leukocyte Common Antigens，Protein Tyrosine Phosphatase Receptor Type C，EC:3.1.3.48
市販薬剤の数	0
治験薬の数	7
研究＆開発段階	Phase 3 Clinical

CD45RO 製品リスト

属性
Antibody (2)Protein (1)
製品ライブラリ
オンライン (3)
種
Mouse (2)Human (1)
タグ
- (2)His Tag (1)
マーカー
Unconjugated (2)PE Labeled (1)

製品番号	種	発現システム	製品説明	タンパク質の構造	純度	特性
CDO-H52H3	Human	HEK293	Human CD45RO Protein, His Tag (MALS verified)
FABm021-01	Mouse	CHO	PE-Labeled Monoclonal Anti-Human CD45RO Antibody, Mouse IgG2a (UCHL1) (0.03% Proclin)
HGS-S249	Mouse	-	Recombinant Monoclonal Anti-CD45RO Antibody, Mouse (4C8)

総数量3

CD45RO分子の別称

B220, CD45, CD45R, GP180, IMD105, L-CA, LCA, LY5, T200

治験薬に関する情報

英語名	研究コード	研究開発ステージ	会社	適応症	臨床試験
Immunomodulatory progenitor cell therapy (Celixir)		Phase 3 Clinical	Celixir	Cardiomyopathies; Endomyocardial Fibrosis	詳細
I-131-Apamistamab	BC8-I-131; BC-8; 131IBC8; I-131 BC-8	Phase 3 Clinical	Fred Hutchinson Cancer Research Center	Anemia, Refractory, with Excess of Blasts; Anemia, Sickle Cell; Anemia, Sideroblastic; Angioimmunoblastic T-cell Lymphoma; Burkitt Lymphoma; Graft vs Host Disease; Hematopoietic stem cell transplantation (HSCT); Hodgkin Disease; Intraocular Lymphoma; Leukemia; Leukemia, Hairy Cell; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Lymphomatoid Granulomatosis; Mycosis Fungoides; Myelodysplastic Syndromes; Neoplasms, Gonadal Tissue; Neoplastic Cells, Circulating; Pancytopenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sezary Syndro	詳細
At 211 MAb BC8-B10		Phase 2 Clinical	Fred Hutchinson Cancer Research Center	Neoplasms	詳細
211At-BC8-B10	211At-BC8-B10	Phase 2 Clinical	Fred Hutchinson Cancer Research Center, National Cancer Institute	Hematologic Neoplasms; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Lymphoma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma	詳細
CD45BE-HSPC cells therapy (Kite Pharma)		Phase 1 Clinical	Kite Pharma	Hodgkin Disease; Lymphoma, B-Cell; Lymphoma, T-Cell; Richter's Syndrome	詳細
CART-45 cells therapy (Kite Pharma)		Phase 1 Clinical	Kite Pharma	Hodgkin Disease; Lymphoma, B-Cell; Lymphoma, T-Cell; Richter's Syndrome	詳細
TSC-102	TSC-102-A03; TSC-102-A0301; TSC-102; TSC-102-A01	Phase 1 Clinical	TScan Therapeutics Inc	Hematologic Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma	詳細

詳細
製品リスト
治験薬に関する情報

ウェブサイトに関するフィードバック

お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8